Retinoic Acid Receptor Agonists
| Cat. No. | Product Name / Activity |
|---|---|
| 4046 | AC 261066 |
| RARβ2 agonist | |
| 2852 | Adapalene |
| RARβ and RARγ agonist | |
| 0760 | AM 580 |
| Retinoic acid analog; RARα agonist | |
| 3507 | AM 80 |
| RARα agonist; anticancer agent | |
| 3505 | BMS 753 |
| RARα-selective agonist | |
| 3410 | BMS 961 |
| Selective RARγ agonist | |
| 2554 | CD 1530 |
| Potent and selective RARγ agonist | |
| 3824 | CD 2314 |
| Selective RARβ agonist | |
| 1549 | CD 437 |
| RARγ-selective agonist | |
| 2020 | Ch 55 |
| Potent RAR agonist | |
| 6873 | DC 271 |
| Fluorescent retinoic acid analog; solvochromatic probe | |
| 0695 | Retinoic acid |
| Endogenous retinoic acid receptor agonist | |
| 0761 | TTNPB |
| Retinoic acid analog; RAR agonist |
Cancer Research Product Guide
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyRequest PDFRXR and RAR Scientific Review
Our Retinoid Receptors review gives a summary of retinoic acid and retinoid X receptor pharmacology, and the modulation of retinoid signaling.
Request copyRequest PDF